Study of the immune-microenvironment in Multiple Myeloma: understanding the effects of immunomodulatory drugs and the contribution of immune checkpoints in disease progression

Federica Costa(University of Parma)

DSpasce-unipr

March 1, 2019

Cited by 0

Related Papers

Checkpoint Inhibition in Myeloma: Opportunities and Challenges

|Frontiers in Immunology|2018|62

Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties

|Oncotarget|2017|30

PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients

|Frontiers in Immunology|2021|20